CellRapeutics™ Leukopak from Cutaneous Lupus Erythematosus Donor (XS-0426-XU278)

Name: CellRapeutics™ Leukopak from Cutaneous Lupus Erythematosus Donor
SKU: XS-0426-XU278
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Sourced from donors with Cutaneous Lupus Erythematosus, this product consists of a high-yield collection of PBMCs primed by skin-specific autoimmune triggers. The cell population is enriched with plasmacytoid dendritic cells and T-cell subsets that express skin-homing markers. This Leukopak is specifically curated for research into the type I interferon signature and the mechanisms of lymphocyte-mediated keratinocyte injury in localized autoimmune dermatoses.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Cutaneous Lupus Erythematosus Donor

Cat. No.
XS-0426-XU278

Donor Age
Young Adult, Middle-Aged

Donor Health
Diagnosed with Cutaneous Lupus. The leukocyte population reflects a photosensitive autoimmune state, featuring skin-homing lymphocyte expansion and systemic signatures of type I interferon pathway activation.

Ethnicity
Diverse backgrounds available, predominantly African American and Hispanic cohorts.

Anticoagulant
Acid Citrate Dextrose, prioritized to preserve the skin-tropic T cell subsets and UV-sensitive immune signatures.

Additional Donor Information
Each lot features a Leukopak from donors with skin-manifested lupus. Profiles focus on skin lesion activity and systemic involvement exclusion, facilitating research on skin-homing lymphocyte subsets.

Clinical Profile
Specific subtype, biopsy confirmation, severity index score, and presence or absence of systemic involvement.

Additional Information

Medication History
Available upon request. Records of topical agents, antimalarials, and systemic immunomodulatory medications.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Cutaneous Lupus Erythematosus Donor, Leukopak, Cutaneous Lupus Erythematosus

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Cutaneous Lupus Erythematosus Donor (XS-0426-XU278). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.